Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 231 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2784 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-04-27 2023-06-02 190862
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-05-19 2023-06-02 192788
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-06-29 2023-11-06 196949
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-07-21 2023-11-06 199515
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-08 2024-02-23 212934
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-15 2024-01-05 213553
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-15 2024-01-05 213576
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-22 2024-01-05 214223
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-12-22 2024-02-23 214235
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2024-04-12 2024-04-26 225008
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2017-08-24 2017-09-22 20281
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2018-01-18 2018-02-12 36432
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2018-03-13 2018-07-03 42717
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-04-13 2020-05-22 111901
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2020-05-08 2020-05-22 114285
APO-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2020-06-04 2020-07-28 116533
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2020-08-06 2020-11-28 121891
APO-DEFERASIROX 250MG TABLET FOR SUSPENSION Resolved 2023-09-07 2023-09-15 203819

Showing 3021 to 3038 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NAPRO-NA 275MG TABLET Discontinued 2018-09-08 2018-09-15 60657
APO-NAPRO-NA DS 550MG TABLET Discontinued 2018-09-08 2018-09-15 60660
APO NAPROXEN TAB 125MG 125MG TABLET Discontinued 2018-09-08 2019-08-08 60663
APO-NAPROXEN 250MG TABLET Discontinued 2018-09-08 2018-09-15 60666
APO-OLANZAPINE 10.0MG TABLET Discontinued 2018-09-08 2018-12-18 60672
APO-OXAZEPAM 10MG TABLET Discontinued 2018-09-08 2019-08-30 60675
APO-OXAZEPAM 15MG TABLET To be discontinued 2018-09-08 2018-09-08 60678
APO-OXAZEPAM 30MG TABLET Discontinued 2018-09-08 2019-06-12 60681
APO-PAROXETINE 20MG TABLET Discontinued 2018-09-08 2018-09-15 60684
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO-QUETIAPINE 300MG TABLET Discontinued 2018-09-08 2018-12-28 60708
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-07-13 60758
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-02-13 60763

Showing 241 to 260 of 356